How Did We Get COVID Vaccines So Quickly?

You might have heard that vaccine trials are currently underway in Seattle. What exactly is being tested? How much longer will these tests take? And when can we expect a vaccine against the novel coronavirus? We chat with Dr. Benjamin Neuman, one of the world’s experts on coronavirus, and Daniel Wrapp, one of the scientists who mapped the structure of the protein coronavirus uses to infect your cells, to help us answer these questions.

#moderna #vaccine #coronavirus #covid-19 #covid19

Find us on all these places:

Executive Producers:
George Zaidan
Hilary Hudson

Andrew Sobey
Elaine Seward

Samantha Jones, PhD

Scientific consultants:
Benjamin Neuman, PhD
Daniel Wrapp
Michelle Boucher, PhD
Leila Duman, PhD

Special Thanks:
Ruben Rodriguez


Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
A Fusion Peptide in the Spike Protein of MERS Coronavirus
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
How SARS hijacks host cells
Mechanisms of viral assembly
Timely development of vaccines against SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles
Scientists figure out how new coronavirus breaks into human cells
A Spotlight on Viruses—Application of Click Chemistry to Visualize Virus-Cell Interactions
How Viruses Invade Cells
The proximal origin of SARS-CoV-2
Thousands of scientists are racing to find a vaccine for coronavirus. 41 possibilities are in the works
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
New coronavirus stable for hours on surfaces
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
Vaccines and Antiviral Drugs in Pandemic Preparedness
On the binding affinity of macromolecular interactions: daring to ask why proteins interact
Coronavirus envelope protein: current knowledge
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Leave a Reply

Your email address will not be published. Required fields are marked *